Plerixafor, a reversible CXCR4 antagonist, significantly increases the yield of CD34 + peripheral blood cells in randomized studies, thereby enabling more patients to proceed to autologous transplant.

A simple algorithm to aid in the selection of appropriate disease modifying therapies (DMTs) reduces racial disparities in patients with relapsing multiple sclerosis (MS), early new research showed.

As the world races to build artificial superintelligence, one maverick bioengineer is testing how much unprogrammed intelligence may already be lurking in our simplest algorithms to determine whether ...

Inspired by a theoretical model of particles moving around on a chessboard, new robot swarm research shows that, as magnetic interactions increase, dispersed 'dumb robots' can abruptly gather in large ...